![]() |
市场调查报告书
商品编码
1949548
蒸气高压釜市场 - 全球产业规模、份额、趋势、机会及预测(按类型、应用、地区和竞争格局划分,2021-2031年)Steam Autoclaves Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Configuration, By Application (Medical Steam Autoclaves, Dental Steam Autoclaves, Laboratory Steam Autoclaves), By Region & Competition, 2021-2031F |
||||||
全球蒸气高压釜市场预计将从 2025 年的 15.9 亿美元成长到 2031 年的 22.8 亿美元,复合年增长率为 6.19%。
蒸气高压釜是一种特殊的加压容器,利用高压饱和蒸气对工业和医疗设备进行消毒灭菌,从而消除微生物。推动全球市场发展的关键因素是医疗相关感染的日益增多以及医疗机构对安全通讯协定的严格执行,这都要求采用高效的灭菌流程。世界卫生组织(WHO)估计,到2024年,全球每年将有约1.36亿例抗药性医疗相关感染,凸显了可靠的灭菌方法对于保障病患安全和对抗抗菌素抗药性的重要性。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 15.9亿美元 |
| 市场规模:2031年 | 22.8亿美元 |
| 复合年增长率:2026-2031年 | 6.19% |
| 成长最快的细分市场 | 直立式高压釜 |
| 最大的市场 | 北美洲 |
蒸气高压釜市场进一步扩张的主要挑战之一是蒸气灭菌与先进医疗设备中常用的热敏材料不相容。许多现代手术器械都包含易受高温高湿环境劣化的精密电子元件和塑料,这迫使医疗机构采用环氧乙烷和等离子体等其他低温灭菌技术。这项限制使得蒸气高压釜的应用仅限于耐热器械,并要求医疗机构投资多种灭菌方法,从而增加营运预算负担。
诊断和外科手术量的增加是蒸气高压釜需求的主要驱动因素。随着患者数量的增加,快速灭菌循环对于维持器械的可用性至关重要。医院和门诊中心正面临前所未有的容量需求,促使各机构升级到更高容量的系统,以便能够处理大量手术托盘而不会出现营运瓶颈。近期统计数据量化了临床活动的激增。根据美国医院协会 (AHA) 于 2025 年 1 月发布的报告《2025 年美国医院速览》,美国医院总入院人数将达到约 3,450 万,这凸显了高效的灭菌基础设施对于支持如此大规模的患者照护的重要性。
此外,製药和生技领域研发活动的拓展也是市场成长的主要驱动力。严格的灭菌对于维持生物加工和药物研发过程中的无菌条件至关重要,实验室通常使用蒸气高压釜对培养基、玻璃器皿和生物危害废弃物进行消毒。这可以防止交叉污染影响实验的可靠性。 Fierce Biotech 于 2025 年 3 月发布的对主要製药公司研发预算的分析表明,各公司在该领域的创新投入显着。默克公司以 179 亿美元的投资位居榜首,显示其在设备采购方面投入了大量资金。此外,STERIS plc 在 2025 年 5 月的新闻稿中宣布,其全年营收成长 6% 至 55 亿美元,显示全球对感染预防解决方案的需求持续旺盛。
全球蒸气高压釜市场成长的一大挑战是蒸气灭菌与现代医疗设备中使用的热敏元件的材质不相容。蒸气高压釜的工作原理是将器械暴露于高温高压的饱和蒸气中,该过程能有效灭菌耐用金属,但劣化内视镜等复杂器械中使用的敏感黏合剂、聚合物和电子元件。这种物理限制使得蒸气高压釜无法作为无菌处理领域的通用解决方案,从技术上限制了其效用。因此,医疗机构不得不将资本支出转向其他低温灭菌方法或外包服务,从而有效地缩小了蒸气灭菌设备在更广泛的灭菌生态系统中的潜在市场规模。
这种不相容性导致灭菌流程支离破碎,阻碍了蒸气技术在日益增长的高级外科器械市场中占有一席之地。依赖无法承受蒸气循环的器械需要对各种再处理方法进行大量投资,这直接限制了标准高压釜的可用性。根据医疗设备再处理协会 (AMDR) 统计,其成员公司在 2024 年向医疗机构提供了 3,630 万件再处理过的医疗设备。如此庞大的库存需要特殊的处理方法,而标准蒸气循环难以满足这些需求,这凸显了由于热力限制,蒸气高压釜无法覆盖的巨大市场规模。
物联网整合实现远端监控,从根本上改变了全球蒸气高压釜市场,实现了即时连接和数据驱动的运作管理。越来越多的医疗机构部署智慧灭菌系统,这些系统能够自动记录循环参数和诊断分析结果,从而确保严格遵守安全标准,同时最大限度地降低人工记录带来的风险。这种向互联基础设施的转变得到了各大行业联盟的支持,这些联盟在采购中优先考虑数位化准备。例如,Tatnauer 在 2025 年 1 月的新闻稿中宣布,其支援物联网的 T-Top高压釜获得了 Premier 颁发的「技术突破」认证。 Premier 是一家医疗保健改进公司,服务约三分之二的美国医疗机构。
同时,全球严格的脱碳要求和降低营运成本的需求促使节能型热回收系统成为关键发展趋势。製造商正在开发采用先进资源回收架构的新一代高压高压釜,显着降低蒸气产生和腔室冷却所需的水和能源消耗。这项技术变革直接得益于公司积极的永续性目标,这些目标影响着公司的产品创新方向。根据Getinge于2025年3月发布的2024年度报告,公司製定了到2030年将范围1和范围2温室气体绝对排放减少90%的战略目标,这正推动公司加速其生态高效灭菌技术的商业化进程。
The Global Steam Autoclaves Market is projected to expand from USD 1.59 Billion in 2025 to USD 2.28 Billion by 2031, reflecting a compound annual growth rate of 6.19%. Steam autoclaves operate as specialized pressure chambers that utilize high-pressure saturated steam to decontaminate and sterilize industrial and medical equipment by eliminating microorganisms. The primary force driving this global market is the rising prevalence of healthcare-associated infections combined with the strict enforcement of safety protocols across medical facilities, which demand robust sterilization cycles. Highlighting this urgency, the World Health Organization estimated in 2024 that approximately 136 million antibiotic-resistant healthcare-associated infections occur globally each year, underscoring the critical need for reliable sterilization methods to ensure patient safety and combat antimicrobial resistance.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.59 Billion |
| Market Size 2031 | USD 2.28 Billion |
| CAGR 2026-2031 | 6.19% |
| Fastest Growing Segment | Vertical Stem Autoclaves |
| Largest Market | North America |
One significant challenge hindering the broader expansion of the steam autoclaves market is the incompatibility of steam sterilization with heat-sensitive materials prevalent in advanced medical devices. Many modern surgical instruments incorporate delicate electronics or plastics that degrade under high temperatures and moisture, compelling healthcare providers to adopt alternative low-temperature technologies such as ethylene oxide or plasma. This limitation confines the application of steam autoclaves to heat-resistant tools and requires facilities to invest in diverse sterilization methodologies, which can place a strain on operational budgets.
Market Driver
The increasing volume of diagnostic and surgical procedures acts as a primary catalyst for steam autoclave demand, as higher patient turnover necessitates rapid sterilization cycles to maintain instrument availability. Hospitals and outpatient centers are facing unprecedented throughput requirements, forcing facilities to upgrade to high-capacity systems capable of processing heavy loads of surgical trays without causing operational bottlenecks. This surge in clinical activity is quantified by recent statistics; according to the American Hospital Association's "Fast Facts on U.S. Hospitals, 2025" report from January 2025, total admissions in all U.S. hospitals reached nearly 34.5 million, emphasizing the critical need for efficient sterilization infrastructure to support this massive scale of patient care.
Additionally, the expansion of pharmaceutical and biotechnology R&D activities significantly drives market growth, as rigorous sterilization is mandatory for maintaining aseptic conditions during bioprocessing and drug discovery. Research laboratories depend heavily on steam autoclaves to decontaminate culture media, glassware, and biohazardous waste, ensuring that experimental integrity is not compromised by cross-contamination. This sector's investment in innovation is illustrated by Fierce Biotech's March 2025 analysis of top pharma R&D budgets, where Merck led with an investment of $17.9 billion, demonstrating the substantial capital supporting equipment procurement. Furthermore, STERIS plc reported in its May 2025 press release that full-year revenue increased 6% to $5.5 billion, indicating sustained global demand for infection prevention solutions.
Market Challenge
A significant challenge impeding the growth of the Global Steam Autoclaves Market is the material incompatibility of steam sterilization with heat-sensitive components found in modern medical instrumentation. Steam autoclaves function by subjecting instruments to high-pressure saturated steam at elevated temperatures, a process that effectively sterilizes durable metals but degrades delicate adhesives, polymers, and electronics used in complex devices like endoscopes. This physical limitation restricts steam autoclaves from serving as a universal solution for sterile processing departments, creating a technical ceiling on their utility. Consequently, healthcare facilities are compelled to divert capital expenditure toward alternative low-temperature modalities or outsourced services, effectively shrinking the addressable market for steam-based equipment within the broader sterilization ecosystem.
This incompatibility forces a fragmentation of sterilization workflows, preventing steam technology from capturing the growing segment of advanced surgical tools. The reliance on devices that cannot withstand steam cycles necessitates substantial investment in diverse reprocessing methodologies, directly limiting the procurement of standard autoclaves. According to the Association of Medical Device Reprocessors, member companies supplied 36.3 million reprocessed medical devices to healthcare facilities in 2024. This substantial volume of inventory, which requires specialized handling often outside the capabilities of standard steam cycles, underscores the magnitude of the market segment that steam autoclaves fail to capture due to thermal limitations.
Market Trends
The integration of IoT for remote monitoring and control is fundamentally reshaping the Global Steam Autoclaves Market by enabling real-time connectivity and data-driven operational management. Facilities are increasingly deploying smart sterilization systems that automatically capture cycle parameters and diagnostic analytics, thereby ensuring strict compliance with safety standards while minimizing the risks associated with manual record-keeping. This transition towards connected infrastructure is validated by major industry alliances that prioritize digital readiness in procurement; for instance, Tuttnauer announced in a January 2025 press release that its IoT-enabled T-Top Autoclaves received a technology breakthrough designation from Premier, Inc., a healthcare improvement company serving approximately two-thirds of all U.S. healthcare providers.
Simultaneously, the development of energy-efficient heat recovery systems has emerged as a critical trend driven by stringent global decarbonization mandates and the need to reduce operational expenditures. Manufacturers are engineering next-generation autoclaves featuring advanced resource recovery architectures that significantly lower the water and energy intensity required for steam generation and chamber cooling. This engineering shift is directly supported by aggressive corporate sustainability goals influencing product innovation pipelines; according to Getinge's "Annual Report 2024" published in March 2025, the company has committed to a strategic target of reducing its absolute Scope 1 and 2 greenhouse gas emissions by 90% by 2030, a directive that is accelerating the commercialization of their eco-efficient sterilization technologies.
Report Scope
In this report, the Global Steam Autoclaves Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Steam Autoclaves Market.
Global Steam Autoclaves Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: